RILPIVIRINE (rilpivirine) by PharmaIN is emtricitabine, rilpivirine and tenofovir disoproxil fumarate tablets are a fixed-dose combination of the antiretroviral drugs ftc, rpv, and tdf [see ].
Drug data last refreshed Yesterday
Emtricitabine, rilpivirine and tenofovir disoproxil fumarate tablets are a fixed-dose combination of the antiretroviral drugs FTC, RPV, and TDF [see ].
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine
Worked on RILPIVIRINE at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.